Immunopathologic features of pemphigus in the east mediterranean region of Turkey: A prospective study

SKINmed

Volumn 8, Issue 1, 2010, Pages 12-16

  Akman, Ayse ^a   Uzun, Soner ^b   Alpsoy, Erkan ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

^b CUKUROVA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PATHOLOGY; PEMPHIGUS; PROSPECTIVE STUDY; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MALE; MIDDLE AGED; PEMPHIGUS; PROSPECTIVE STUDIES; TURKEY; YOUNG ADULT;

EID: 77957688554     PISSN: 15409740     EISSN: 17517125     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Nousari HC, Anhalt GJ. Pemphigus vulgaris, paraneoplastic pemphigus and pemphigus foliaseus. In: Kanitas J, Vassileva S, Woodley D, eds. Diagnostic Immunohistochemistry of the Skin. Philadelphia, PA: Chapman and Hall; 1998:74-84.
2. Jordon RE. Atlas of Bullous Disease. Philadelphia, PA: Churchill Livingstone; 2000.
3. Mutasim DF, Adams MB. Immunofluorescence in dermatology. J Am Acad Dermatol. 2001;45:803-822.
4. Hashimoto T. Recent advances in the study of the pathophysiology of pemphigus. Arch Dermatol Res. 2003;295(suppl 1):S2-S11.
5. Jolıgan JE, Kruisbeek AM, Margulies DH, et al. In: Coligan JE, Kruiskbeek AM, Margulies DH, Shevach EM, eds. Current Protocols in Immunology. Indianapolis, IN: John Wiley and Sons, Inc; 2001:831-841.
6. Anhalt GJ, Kim S, Stanley JR. Para neoplatic pemphigus. An autoimmune mucocuteneouus disease associated with neoplasia. N Engl J Med. 1990;323:1729-1735.
7. Amagai M, Klaus-Kovtun V, Stanley JR. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell. 1991;67:869-877.
8. Ishii K, Amagai M, Hall RP, et al. Characterization of autoantibodies in pemphigus using antigen-specific ELISAs with baculovirus expressed recombinant desmogleins. J Immunol. 1997;159:2010-2017.
9. Harman KE, Gratian MJ, Seed PT, et al. Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3. Clin Exp Dermatol. 2000;25:236-240.
10. Hahn K, Kippes W, Amagai M, Rzany B, Bröcker EB, Zillikens D. Clinical aspects and immunopathology in 48 patients with pemphigus. Hautarzt. 2000;51:670-677.
11. Amagai M, Komai A, Hashimoto T, et al. Usefulness of enzymelinked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus. Br J Dermatol. 1999;140:351-357.
12. Cheng SW, Kobayashi M, Kinoshita-Kuroda K, et al. Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3. Br J Dermatol. 2002;147:261-265.
13. Fitzpatrick RE, Mewcomer VD. The correlation of disease activity an antibody titers in pemphigus. Arch Dermatol. 1980;116:285-290.
14. David M, Weisman-Katzenelson V, Ben-Chetrit A. The usefulness of immunofluorescent tests in pemphigus patients in clinical remission. Br J Dermatol. 1989;120:391-395.
15. Aoyama Y, Tsujimura Y, Funabashi M, et al. An experience for ELISA for desmoglein 1, suggesting a possible diagnostic help to determine the initial therapy for pemphigus foliaceus. Eur J Dermatol. 2000;10:18-21.
16. Harman KE, Seed PT, Gratian MJ, et al. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels. Br J Dermatol. 2001;144:775-780.
17. Uzun S, Durdu M, Akman A, et al. Pemphigus in the Mediterranean region of Turkey: a study of 148 cases. Int J Dermatol. 2006;45:523-528.
18. Carson PJ, Hameed A, Ahmed AR. Influence of treatment on the clinical course of pemphigus vulgaris. J Am Acad Dermatol. 1996;34:645-652.
19. Aberer W, Wolff-Schreiner EC, Stingl G, Wolff K. Azathioprine in the treatment of pemphigus vulgaris. A long-term follow-up. J Am Acad Dermatol. 1987;16:527-533.
20. Beutner EH, Jordon RE, Chorzelski TP. The immunopathology of pemphigus and bullous pemphigoid. J Invest Dermatol. 1968;51:63-80.
21. David M, Weisman-Katzenelson V, Ben-Chetrit A, et al. The usefulness of the immunofluorescent tests in pemphigus patients in clinical remission. Br J Dermatol. 1989;120:391-395.
22. Bradwell AR, Stokes RP, Johnson GD. Atlas of Autoantibody Patterns on Tissues. Birmingham, AL: KNP Group Ltd; 1997.
23. Mutasim DF, Pelc NJ, Supapannachart N. Established methods in the investigation of bullous diseases. Dermatol Clin. 1993;11:399-418.
24. Mutasim DF, Adams BB. Immunofluorescence in dermatology. J Am Acad Dermatol. 2001;45:803-822.
25. Tsankov N, Vassileva S, Kamarashev J, et al. Epidemiology of pemphigus in Sofia, Bulgaria: a 16-year retrospective study (1980-1995). Int J Dermatol. 2000;39:104-108.
26. Micali G, Musumeci ML, Nasca MR. Epidemiologic analysis and clinical course of 84 consecutive cases of pemphigus in eastern Sicily. Int J Dermatol. 1998;37:197-200.
27. Tallab T, Joharji H, Bahamdan K, et al. The incidence of pemphigus in the southern region of Saudi Arabia. Int J Dermatol. 2001;40:570-572.
28. Brenner S, Mashiah J, Tamir E, et al. PEMPHIGUS: an acronym for a disease with multiple etiologies. Skinmed. 2003;2:163-167.
29. Brenner S, Tur E, Shapiro J, et al. Pemphigus vulgaris: environmental factors. Occupational, behavioral, medical, and qualitative food frequency questionnaire. Int J Dermatol. 2001;40:562-569.
30. Tron F, Gilbert D, Mouquet H, et al. Genetic factors in pemphigus. J Autoimmun. 2005;24:319-328.
31. Ioannides D, Hytioglous P, Phelps RG, et al. Regional variation in the expression of pemphigus foliaceus, pemphigus erythematosus and pemphigus vulgaris antigens in human skin. J Invest Dermatol. 1991;96:159-161.
32. Jamora MJ, Jiao D, Bystryn JC. Antibodies to desmoglein 1 and 3, and the clinical phenotype of pemphigus vulgaris. J Am Acad Dermatol. 2003;48:976-977.
33. Baykal C, Azizlerli G, Thoma-Uszynski S, et al. Pemphigus vulgaris localized to the nose and cheeks. J Am Acad Dermatol. 2002;47:875-880.
34. Hertl M, Veldman C. Pemphigus-paradigm of autoantibodymediated autoimmunity. Skin Pharmacol Appl Skin Physiol. 2001;14:408-418.
35. Green KJ, Gaudry CA. Are desmosomes more than tethers for intermediate filaments? Nat Rev Mol Cell Biol. 2000;1:209-216.
36. Kljuic A, Bazzi H, Sundberg JP, et al. Desmoglein 4 in hair follicle differentiation and epidermal adhesion: evidence from inherited hypotrichosis and acquired pemphigus vulgaris. Cell. 2003;113:249-260.
37. Bystryn JC, Akman A, Jiao D. Limitations in enzyme-linked immunosorbent assays for antibodies against desmogleins 1 and 3 in patients with pemphigus. Arch Dermatol. 2002;138:1252-1253.